five

Study Results - ClinicalTrials NCT00376168

收藏
DataONE2017-11-02 更新2024-06-26 收录
下载链接:
https://search.dataone.org/view/null
下载链接
链接失效反馈
官方服务:
资源简介:
Results from Study PB-06-001, ‘A Phase III Multicenter, Randomized, Double-Blind Trial to Assess the Safety and Efficacy of Two Parallel Dose Groups of Plant Cell Expressed Recombinant Human Glucocerebrosidase (prGCD) in Patients with Gaucher Disease’. ERT-naïve adult patients (N=32) with a total treatment duration of 9 months (study started on August 2007 and ended September 2009). Results available at ClinicalTrials.gov: NCT00376168. Please acknowledge the National Library of Medicine (NLM) in subsequent use of this document. While using these results please cite the study in PLOS One and acknowledge the National Library of Medicine.
创建时间:
2017-11-02
5,000+
优质数据集
54 个
任务类型
进入经典数据集
二维码
社区交流群

面向社区/商业的数据集话题

二维码
科研交流群

面向高校/科研机构的开源数据集话题

数据驱动未来

携手共赢发展

商业合作